Compare MDLN & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDLN | GEHC |
|---|---|---|
| Founded | 1966 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.0B | 27.9B |
| IPO Year | 2025 | 2022 |
| Metric | MDLN | GEHC |
|---|---|---|
| Price | $36.75 | $68.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 23 | 13 |
| Target Price | $50.48 | ★ $88.38 |
| AVG Volume (30 Days) | ★ 6.7M | 2.5M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | 0.23 | ★ 0.85 |
| Revenue | ★ $28,432,000,000.00 | $20,625,000,000.00 |
| Revenue This Year | $10.88 | $7.12 |
| Revenue Next Year | $7.69 | $4.45 |
| P/E Ratio | $160.26 | ★ $82.02 |
| Revenue Growth | ★ 11.47 | 4.84 |
| 52 Week Low | $32.49 | $58.75 |
| 52 Week High | $50.88 | $89.77 |
| Indicator | MDLN | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 54.11 | 44.64 |
| Support Level | $35.07 | $68.88 |
| Resistance Level | $37.79 | $72.77 |
| Average True Range (ATR) | 1.23 | 1.51 |
| MACD | 0.37 | -0.75 |
| Stochastic Oscillator | 98.54 | 17.06 |
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).